Control computerized tomography in neoadjuvant chemotherapy for muscle invasive urinary bladder cancer, has no value for treatment decisions and low correlation with nodal status
CONCLUSIONS: CCT prior to the final treatment cycle of NAC in MIBC, leads to a low percentage of treatment strategy changes and cCT cannot accurately predict pN-status.PMID:34590930 | DOI:10.1080/21681805.2021.1981996
Source: Scandinavian Journal of Urology - Category: Urology & Nephrology Authors: S Tenninge H Mogos E Eriksson H Netterling S Pelander M Johansson F Alamdari Y Huge F Aljabery J Svensson J Styrke A Sherif Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | Chemotherapy | Computers | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Pathology | PET Scan | Statistics | Study | Sweden Health | Urology & Nephrology